Professor Andrew Wardley is a Consultant Medical Oncologist and leading expert in breast cancer treatment and research. He is Medical Director of The NIHR Manchester Clinical Research Facility at The Christie, Honorary Professor in Breast Medical Oncology and Lead for The Christie Manchester Breast Centre Research Team.
After graduating from The University of Manchester in 1989, he completed his general medical training in 1993, and specialist Medical Oncology training, including am MSc and research doctorate in 2000. In 2001 he took up the post of Consultant Medical Oncologist for breast cancer at The Christie, he was fundamental in developing The Christie Hospital Breast Cancer Research Team and was a founding member of the Manchester Breast Centre.
Professor Wardley is known internationally for his research into breast cancer and is widely published. His focus is on identifying resistance pathways in advanced breast cancer and introducing new treatments. He has been the Principal Investigator for a number of national and international trials and The Christie has become one of the largest Early Phase Trials Units in the world.
MB. ChB. University of Manchester 1989
MRCP Royal College of Physicians 1993
MSc. University of Manchester 2000
MD. University of Manchester 2000
CCST Medical Oncology JCHMT 2000
FRCP Royal College of Physicians of London 2005